Grabarczyk P - Search Results

1

Genetically modified dendritic cells--a new, promising cancer treatment strategy?

Wysocki PJ, Grabarczyk P, Mackiewicz-Wysocka M, Kowalczyk DW, Mackiewicz A. Wysocki PJ, et al. Among authors: grabarczyk p. Expert Opin Biol Ther. 2002 Dec;2(8):835-45. doi: 10.1517/14712598.2.8.835. Expert Opin Biol Ther. 2002. PMID: 12517263 Review.

2

Expression of PiT1 and PiT2 retroviral receptors and transduction efficiency of tumor cells.

Grabarczyk P, Wysocki PJ, Gryska K, Mackiewicz A. Grabarczyk P, et al. Acta Biochim Pol. 2002;49(2):333-9. Acta Biochim Pol. 2002. PMID: 12362974 Free article.

3

Recent developments in retroviral gene delivery systems.

Wysocki PJ, Grabarczyk P, Mackiewicz A. Wysocki PJ, et al. Among authors: grabarczyk p. Expert Opin Biol Ther. 2001 Nov;1(6):911-3. doi: 10.1517/14712598.1.6.911. Expert Opin Biol Ther. 2001. PMID: 11728224

4

IL-6 and GM-CSF in tumor rejection model of renal cell cancer.

Wysocki PJ, Kowalczyk DW, Izycki D, Grabarczyk P, Kwias Z, Mackiewicz A. Wysocki PJ, et al. Among authors: grabarczyk p. Adv Exp Med Biol. 2001;495:379-83. doi: 10.1007/978-1-4615-0685-0_55. Adv Exp Med Biol. 2001. PMID: 11774597 No abstract available.

5

Improving the retroviral vector (RV) systems for immunotherapy of cancer.

Grabarczyk P, Gryska K, Wysocki PJ, Izycki D, Mackiewicz A. Grabarczyk P, et al. Adv Exp Med Biol. 2001;495:389-92. doi: 10.1007/978-1-4615-0685-0_57. Adv Exp Med Biol. 2001. PMID: 11774599 No abstract available.

6

Humoral responses to melanoma vaccine, genetically modified with interleukin 6 and soluble interleukin 6 receptor.

Nawrocki S, Łaciak M, Izycki D, Gryska K, Wysocki PJ, Grabarczyk P, Karczewska A, Kaczmarek A, Murawa P, Malicki J, Rose-John S, Mackiewicz A. Nawrocki S, et al. Among authors: grabarczyk p. Adv Exp Med Biol. 2001;495:411-8. doi: 10.1007/978-1-4615-0685-0_60. Adv Exp Med Biol. 2001. PMID: 11774603 No abstract available.

7

Flow cytometric cytotoxicity assay with GFP gene modified target cells.

Izycki D, Gryska K, Grabarczyk P, Wysocki PJ, Jarosińska A, Nawrocki S, Kowalczyk DW, Mackiewicz A. Izycki D, et al. Among authors: grabarczyk p. Adv Exp Med Biol. 2001;495:429-34. doi: 10.1007/978-1-4615-0685-0_62. Adv Exp Med Biol. 2001. PMID: 11774605 No abstract available.

8

Loss of tumorigenicity of murine colon carcinoma MC38/0 cell line after transduction with a retroviral vector carrying murine IL-12 genes.

Pajtasz-Piasecka E, Szyda A, Rossowska J, Krawczenko A, Indrová M, Grabarczyk P, Wysocki P, Mackiewicz A, Duś D. Pajtasz-Piasecka E, et al. Among authors: grabarczyk p. Folia Biol (Praha). 2004;50(1):7-14. Folia Biol (Praha). 2004. PMID: 15055737 Free article.

9

Optimization of a retroviral vector for transduction of human CD34 positive cells.

Szyda A, Paprocka M, Krawczenko A, Lenart K, Heimrath J, Grabarczyk P, Mackiewicz A, Duś D. Szyda A, et al. Among authors: grabarczyk p. Acta Biochim Pol. 2006;53(4):815-23. Epub 2006 Dec 11. Acta Biochim Pol. 2006. PMID: 17160143 Free article.

10

In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.

Braun FC, van den Brandt J, Thomas S, Lange S, Schrank J, Gand C, Przybylski GK, Schmoeckel K, Bröker BM, Schmidt CA, Grabarczyk P. Braun FC, et al. Among authors: grabarczyk p. PLoS One. 2015 Sep 1;10(9):e0135444. doi: 10.1371/journal.pone.0135444. eCollection 2015. PLoS One. 2015. PMID: 26327508 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page